Fundraising Fox

Jason Pontin

Investor

General Partner at DCVC (Data Collective) Β· Board director at Tatio Β· Board director at Kanvas Bio Β· Board director at Proxima Bio

Palo Alto, California

Writes $5M – $25M checks Β· typically $15M

About

Jason Pontin is a General Partner at DCVC focused on early-stage computational biology and chemistry startups, having joined in 2021 after serving as Senior Partner at Flagship Pioneering. He cofounded Totus Medicines and previously ran media companies, serving as Editor in Chief and Publisher of MIT Technology Review from 2004 to 2017.

ContactΒ· published on Jason's own website

Invests in

AI & Machine LearningBiotechClimate Tech

Beyond investing

Founded
Pontin founded The Acumen Journal, a magazine about the life sciences. Pontin cofounded MIT Solve in 2015, the institute's open innovation platform. Pontin cofounded Totus Medicines in 2019 with CEO Neil Dhawan.
Education
Studied at Harrow School Studied at Keble College, Oxford
Communities
Pontin delivered a 2013 TED Talk in Long Beach, California titled 'Can Technology solve our big problems?'
Family
Pontin was born in London to a British father, Anthony Charles Pontin, a businessman, and a South African mother, Elaine Howells, an actress.
More
Pontin writes for Wired in the publication's 'IDEAS' channel.

From Jason's own website β€” common ground for a warm intro.

Board director at Tatio

Intro paths

β†’

In turn, Jason can intro founders to Tatio's investors below.

Board director at Kanvas Bio

Intro paths

β†’

In turn, Jason can intro founders to Kanvas Bio's investors below.

Co-founders at Kanvas Bio

MC
Matthew ChengExecutive Officer, Director
HS
Hao ShiExecutive Officer, Director
ID
Iwijn De VlaminckExecutive Officer, Director

Board director at Proxima Bio

Intro paths

β†’

In turn, Jason can intro founders to Proxima Bio's investors below.

Experience

  1. DCVCGeneral Partnercurrent2023 β€” presentPalo Alto, California, United States
  2. DCVCPartner2021 β€” 2023
  3. University of CambridgeGlobal Advisory Board, Cambridge Innovation Hubcurrent2026 β€” presentCambridge
  4. ProximaBoard Membercurrent2026 β€” presentNew York, United States
  5. Dayhoff LabsBoard Membercurrent2025 β€” presentLondon Area, United Kingdom
  6. Kanvas BiosciencesBoard Chaircurrent2023 β€” presentPrinceton, New Jersey, United States
  7. Relation TherapeuticsBoard Membercurrent2022 β€” presentLondon, England, United Kingdom
  8. Totus MedicinesFounding Board Member, Cofounder, and Initial Investor (through Social Impact Capital)current2019 β€” presentGreater Boston Area
  9. WIREDContributing Writercurrent2018 β€” present
  10. Evonetix LtdBoard Member2021 β€” 2026Cambridge
  11. RecycleyeBoard Member2023 β€” 2026Greater London
  12. ZwitterCoBoard Chair2022 β€” 2026Boston, MA
  13. Aquafortus TechnologiesBoard Member2023 β€” 2026Auckland, New Zealand
  14. DVLP MedicinesBoard Chair2022 β€” 2025Boston, Massachusetts, United States
  15. Equilibr.io IncBoard Chair2021 β€” 2025Palo Alto, California, United States
  16. StrateosBoard Chair2021 β€” 2024Menlo Park, California, United States
  17. Adlai Nortye Biopharma Co., Ltd.Scientific Advisory Board Member2020 β€” 2023Boston
  18. Menten AIBoard Observer and Seed Investor (through Social Impact Capital)2020 β€” 2022Greater Boston
  19. Flagship PioneeringSenior Advisor2019 β€” 2020Greater Boston Area
  20. Flagship PioneeringSenior Partner2018 β€” 2019Cambridge, MA
  21. ValoStrategic Advisor2019 β€” 2020
  22. MIT Technology ReviewCEO, Editor in Chief, and Publisher2004 β€” 2017Cambridge, Massachusetts
  23. MIT Enterprise ForumChairman2012 β€” 2017Cambridge, Massachusetts
  24. Acumen Journal of Life SciencesEditor in Chief2002 β€” 2004
  25. Red Herring CommunicationsSuccessively: Managing Editor, the Editor, and Editorial Director1996 β€” 2002
  26. Kennedy School of Government, Harvard UniversityAssociate2001 β€” 2002
  27. InfoWorldSenior Editor1994 β€” 1996

Skills & more

Adobe Creative Suite9Board LevelBoard AdministrationBoard GovernanceDigital Media44Editorial99Publishing99Publications99Magazines93Journalism37Editing99New Media30
+12 moreContent ManagementBloggingOnline PublishingContent StrategyPhotographyWeb ContentSocial MediaNewspapersContent DevelopmentPublic SpeakingWritingPublic Relations

Languages Latin, French, a little modern and ancient Greek.

From Jason's professional profile.

Deals Β· 4

Proxima BioBoard seat

via DCVC (Data Collective) Β· filed Jun 2026 Β· $91.5M raise

Relation Therapeutics Inc.Board seat

via DCVC (Data Collective) Β· filed Dec 2025 Β· $36.2M raise

TatioBoard seat

via DCVC (Data Collective) Β· filed Nov 2022 Β· $2.5M raise

ZwitterCoBoard seat

via DCVC (Data Collective) Β· filed May 2022 Β· $33.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings Β· curated public sources Β· the firm's website.

Colleagues at DCVC (Data Collective)

Network6

Investors connected to Jason in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Jason Pontin?
Jason Pontin is a General Partner at DCVC focused on early-stage computational biology and chemistry startups, having joined in 2021 after serving as Senior Partner at Flagship Pioneering. He cofounded Totus Medicines and previously ran media companies, serving as Editor in Chief and Publisher of MIT Technology Review from 2004 to 2017.
Where does Jason Pontin work?
Jason Pontin is General Partner at DCVC (Data Collective) and Board director at Tatio and Board director at Kanvas Bio and Board director at Proxima Bio.
What does Jason Pontin invest in?
Jason Pontin invests in AI & Machine Learning, Biotech, Climate Tech.
What check size does Jason Pontin write?
Jason Pontin typically writes checks of $5M – $25M.
What boards does Jason Pontin sit on?
Jason Pontin holds tracked board seats at Kanvas Bio, Proxima Bio, Relation Therapeutics Inc., Tatio, Totus Medicines, ZwitterCo.
What companies has Jason Pontin invested in?
Investments tracked here include Totus Medicines.
Where did Jason Pontin go to school?
Jason Pontin studied at University of Oxford (BA, MA (Oxon)); Harrow School.

Founder mafias

Same school

Shared employers